342 related articles for article (PubMed ID: 20004980)
1. Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists.
Jaeger M; Rossler W
Psychiatry Res; 2010 Jan; 175(1-2):58-62. PubMed ID: 20004980
[TBL] [Abstract][Full Text] [Related]
2. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
3. How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed?
Hamann J; Mendel R; Heres S; Leucht S; Kissling W
Eur Neuropsychopharmacol; 2010 Apr; 20(4):276-9. PubMed ID: 20133108
[TBL] [Abstract][Full Text] [Related]
4. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
5. [Treatment adherence in schizophrenia. A comparison between patient's, relative's and psychiatrist's opinions].
Giner J; Cañas F; Olivares JM; Rodriguez A; Burón JA; Rodríguez-Morales A; Roca M
Actas Esp Psiquiatr; 2006; 34(6):386-92. PubMed ID: 17117335
[TBL] [Abstract][Full Text] [Related]
6. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.
Hamann J; Pfeiffer H; Leucht S; Kissling W
Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656
[TBL] [Abstract][Full Text] [Related]
7. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing.
Patel MX; De Zoysa N; Bernadt M; David A
J Psychopharmacol; 2009 Sep; 23(7):789-96. PubMed ID: 18583438
[TBL] [Abstract][Full Text] [Related]
8. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
Patel MX; Nikolaou V; David AS
Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic depot medication and attitudes of community psychiatric nurses.
Patel MX; DE Zoysa N; Baker D; David AS
J Psychiatr Ment Health Nurs; 2005 Apr; 12(2):237-44. PubMed ID: 15788043
[TBL] [Abstract][Full Text] [Related]
10. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
[TBL] [Abstract][Full Text] [Related]
12. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
13. Checking the plausibility of psychiatrists׳ arguments for not prescribing depot medication.
Hamann J; Kissling W; Heres S
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1506-10. PubMed ID: 25037772
[TBL] [Abstract][Full Text] [Related]
14. [What information do patients with schizophrenia have about their illness and treatment?].
Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
Encephale; 2000; 26(5):30-8. PubMed ID: 11192802
[TBL] [Abstract][Full Text] [Related]
15. The attitude of patients towards antipsychotic depot treatment.
Heres S; Schmitz FS; Leucht S; Pajonk FG
Int Clin Psychopharmacol; 2007 Sep; 22(5):275-82. PubMed ID: 17690596
[TBL] [Abstract][Full Text] [Related]
16. Are depot antipsychotics more coercive than tablets? The patient's perspective.
Patel MX; de Zoysa N; Bernadt M; Bindman J; David AS
J Psychopharmacol; 2010 Oct; 24(10):1483-9. PubMed ID: 19304865
[TBL] [Abstract][Full Text] [Related]
17. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
[TBL] [Abstract][Full Text] [Related]
18. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.
Patel MX; Haddad PM; Chaudhry IB; McLoughlin S; Husain N; David AS
J Psychopharmacol; 2010 Oct; 24(10):1473-82. PubMed ID: 19477883
[TBL] [Abstract][Full Text] [Related]
19. What is the schizophrenic patients' level of information about their disease and their treatment?
Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
Encephale; 2000 Oct; 26 Spec No 1():15-22. PubMed ID: 11294058
[TBL] [Abstract][Full Text] [Related]
20. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
